P119 Recurrence Score® result by the 21-gene assay before and after systemic neoadjuvant chemotherapy in patients with HR+ HER2-breast cancer. (April 2023) - Ciriaco, N.; Vieites, B.; Bellet, M.; Castilla, C.; Pardo, P. Gómez; Pérez-Luque, A.; López, M.Á.; Bofill, F.J. Salvador; Alfaro, L.; García, J.M. Pérez; Espinosa-Bravo, M.; Flannery, C.; et al.